Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Yiru Fang

Showing results (81-90 of 251) with videos related to

Pageof 26
Sort By:
Psychiatry Research|August 13, 2013
Lack of association of SLC1A1 variants with schizophrenia in Chinese Han populationWeihong Lu, Haisu Wu, Jun Cai, et al.
BMC Psychiatry|October 30, 2024
The THINC-it tool: temporal sensitivity to change over timeNa Zhu, Jia Huang, YouSong Su, et al.
Frontiers in Psychiatry|March 17, 2020
Functional Status of Hypothalamic-Pituitary-Thyroid and Hypothalamic-Pituitary-Adrenal Axes in Hospitalized Schizophrenics in ShanghaiYuncheng Zhu, Haifeng Ji, Lily Tao, et al.
Psychiatry Research|May 9, 2016
Evaluations of treatment efficacy of depression from perspective of both patients' symptoms and general sense of mental health and wellbeing: A large scale, multi-centered, longitudinal study in ChinaQingzhi Zeng, Wei Chun Wang, Yiru Fang, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 16, 2014
Alterations in effective connectivity anchored on the insula in major depressive disorderSarina J Iwabuchi, Daihui Peng, Yiru Fang, et al.
Journal of Affective Disorders|May 27, 2025
Strategies for antidepressant medications in the maintenance phase: A systematic review and network Meta-analysisZiyi Pan, Haonan Zhang, Binghua Li, et al.
The Journal of Clinical Psychiatry|November 2, 2010
Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychoticsKeming Gao, David E Kemp, Elizabeth Fein, et al.
The International Journal of Neuropsychopharmacology|September 30, 2010
Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorderZuowei Wang, David E Kemp, Philip K Chan, et al.
Journal of Affective Disorders|October 20, 2021
Evaluating the efficacy and moderators of algorithm-guided antidepressant treatments of major depressive disorderHuifeng Zhang, Zhiguo Wu, Lan Cao, et al.
Frontiers in Psychiatry|April 25, 2022
Analysis of Seasonal Clinical Characteristics in Patients With Bipolar or Unipolar DepressionShuqi Kong, Zhiang Niu, Dongbin Lyu, et al.
Pageof 26

Showing results (81-90 of 251) with videos related to

Sort By:
Pageof 26
Psychiatry Research|August 13, 2013
Lack of association of SLC1A1 variants with schizophrenia in Chinese Han populationWeihong Lu, Haisu Wu, Jun Cai, et al.
BMC Psychiatry|October 30, 2024
The THINC-it tool: temporal sensitivity to change over timeNa Zhu, Jia Huang, YouSong Su, et al.
Frontiers in Psychiatry|March 17, 2020
Functional Status of Hypothalamic-Pituitary-Thyroid and Hypothalamic-Pituitary-Adrenal Axes in Hospitalized Schizophrenics in ShanghaiYuncheng Zhu, Haifeng Ji, Lily Tao, et al.
Psychiatry Research|May 9, 2016
Evaluations of treatment efficacy of depression from perspective of both patients' symptoms and general sense of mental health and wellbeing: A large scale, multi-centered, longitudinal study in ChinaQingzhi Zeng, Wei Chun Wang, Yiru Fang, et al.
European Neuropsychopharmacology : the Journal of the European College of Neuropsychopharmacology|September 16, 2014
Alterations in effective connectivity anchored on the insula in major depressive disorderSarina J Iwabuchi, Daihui Peng, Yiru Fang, et al.
Journal of Affective Disorders|May 27, 2025
Strategies for antidepressant medications in the maintenance phase: A systematic review and network Meta-analysisZiyi Pan, Haonan Zhang, Binghua Li, et al.
The Journal of Clinical Psychiatry|November 2, 2010
Number needed to treat to harm for discontinuation due to adverse events in the treatment of bipolar depression, major depressive disorder, and generalized anxiety disorder with atypical antipsychoticsKeming Gao, David E Kemp, Elizabeth Fein, et al.
The International Journal of Neuropsychopharmacology|September 30, 2010
Comparisons of the tolerability and sensitivity of quetiapine-XR in the acute treatment of schizophrenia, bipolar mania, bipolar depression, major depressive disorder, and generalized anxiety disorderZuowei Wang, David E Kemp, Philip K Chan, et al.
Journal of Affective Disorders|October 20, 2021
Evaluating the efficacy and moderators of algorithm-guided antidepressant treatments of major depressive disorderHuifeng Zhang, Zhiguo Wu, Lan Cao, et al.
Frontiers in Psychiatry|April 25, 2022
Analysis of Seasonal Clinical Characteristics in Patients With Bipolar or Unipolar DepressionShuqi Kong, Zhiang Niu, Dongbin Lyu, et al.
Pageof 26